Treating and Preventing Adolescent Mental Health Disorders: Treating and Preventing Adolescent Mental Health Disorders

Home > Table of Contents

Book Title: Treating and Preventing Adolescent Mental Health Disorders > pp. [807]

UNDEFINED: AUTHORS

Treating and Preventing Adolescent Mental Health Disorders

Print ISBN 9780195173642, 2005
pp. [807]

Osteopenia, in anorexia nervosa , 278 , 279–80

Outward Bound , 393–94 , 517 t

Overanxious disorder . See Generalized anxiety disorder

Overweight children and adolescents, professionally administered weight loss programs for , 316–18

P300 (late positive component), in schizophrenia, 91–92 , 93 t, 94

P1/N1 asymmetry, in schizophrenia , 93 t, 94

Pacific Islanders, suicide rate , 436

Pain relievers, opioid , 347 t, 348

PANDAS , 178 , 205–6 , 209

Panic attacks, neuroticism and , 11

Panic control treatment , 190 t, 202 , 203–4

Panic disorder

in children and adolescents , 203

comorbidity , 169 , 169 t

bipolar disorder , 23

bulimia nervosa , 273

description , 166–67

genetics , 180 , 180 t

prevention , 237–38

rating scales , 233–34

signs and symptoms , 165 t

suicidal behavior and , 437

treatment , 190 t, 214 t

in adults , 202–3

in children and adolescents , 203–4

maintenance of gains , 215–16

management of partial response and nonresponse to , 218

Parent(s)

depressed

and offspring depression , 9 , 10 , 16–17 , 65–66

and response to cognitive-behavioral therapy , 36 , 36 f, 37

firearms counseling programs , 466–69 , 467t–468 t

physician likelihood of discussing adolescent mental health problems with , 586 , 586 t

substance use by, and offspring substance use , 392

suicidal, and offspring suicide , 439

Parent-child interaction

in anxiety disorders , 225–27

in suicidal behavior , 439

Parent-child interaction treatment (PCIT), state-level implementation , 556

Parenting dimension

in alcohol use disorders , 361

in anxiety disorders , 227–28

in depression , 15–16

Parity, mental health service , 555 , 620

Paroxetine

for major depressive disorder

in adults , 42

in children and adolescents , 44 , 45 t

for panic disorder , 202

Partnership for a Drug-Free America , 419

Patterson's developmental theory of substance abuse , 414–15

PCP (phencyclidine), 371–72

P50–early sensory gating endophenotype, in schizophrenia , 90 , 106

Peer relations , xxxiii

alcohol use disorders and , 361

anxiety disorders and , 228–31

in children of schizophrenic parents , 148 , 150

depression and , 16

smoking and , 366

Pemoline, for ADHD plus substance use disorder , 408

Penn Resiliency Program , 62–63 , 516 t

Perfectionism, bulimia nervosa and , 313

Performance-limited social anxiety , 164

Perinatal events, anorexia nervosa and , 307–8

Personal Assessment and Crisis Evaluation (PACE) clinic , 111–12

Personal Growth Class (PGC), 472

Personality

anorexia nervosa and , 308

bulimia nervosa and , 313

in children of schizophrenic parents , 153

genetic contributions , 181

major depressive disorder and , 10–11

smoking and , 366–67

Personality disorder(s)

borderline, plus suicidal behavior, dialectical behavioral therapy for , 477

cluster C, plus anorexia nervosa , 272–73

schizotypal , 78 , 153

HPA axis in , 97

movement abnormalities , 84

Pessimistic attributional style

suicidal behavior and , 438

and vulnerability to depression , 11–12

Pharmacotherapy , xxxv–xxxvi

for anorexia nervosa , 291–92 , 297–98

for anxiety disorders

with cognitive-behavioral therapy , 187–88

rationale , 186–87

recommendations , 214 t

research agenda , 251

for bipolar disorder

in adolescents , 51–54 , 52 t

in adults , 50–51

combination therapy , 53–54

maintenance therapy , 54

for bulimia nervosa , 293–94 , 298

for eating disorders , 291–94 , 297–98 , 328–29

for generalized anxiety disorder , 189 t, 194–95 , 197–98

end p.807